Feature Latest Stories
Ramucirumab added to docetaxel significantly improved PFS compared with docetaxel monotherapy as second-line treatment in a phase II study of patients with metastatic transitional cell carcinoma.
- A Network of Your PeersView more >>
Watch Full Video: Dr. Eric D. Hal, MD: Diagnostic accuracy of a defined Immunophenptypic and molecular genetic approach for peripheral T/NK-call lymphomas View Now >>
Roy S. Herbst, MD, PhD, describes the basic premise of immunotherapy and lists some of the key immune checkpoint agents under investigation. View Now >>
Roy S. Herbst, MD, PhD, and Anne S. Tsao, MD, detail which genetic mutations should be identified to help guide treatment choices. View Now >>
Moderator Adam Brufsky, MD, introduces the panelists for the Peer Exchange, and Lee Schwartzberg, MD, describes the profound change genetic testing is making in treatment choices. View Now >>